CRM Nepal conducts lab test of CAR-T cell therapy

This is the first time the treatment technology is tested successfully in Nepal, the organisation says.

Centre for Regenerative Medicine Nepal (CRM Nepal) has successfully conducted a test of the US FDA-certified CD-19 CAR in the laboratory.